Ratings Molina Healthcare, Inc.

Equities

Market Closed - Nyse Other stock markets 21:00:02 08/07/2025 BST			5-day change	1st Jan Change
231.02 ^USD	-0.68%		-24.57%	-20.63%

07-08	Deutsche Bank Adjusts Price Target on Molina Healthcare to $330 From $368, Maintains Hold Rating	MT
07-07	Health Care Declines After Molina Warning - Health Care Roundup	DJ

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

With a P/E ratio at 11.14 for the current year and 9 for next year, earnings multiples are highly attractive compared with competitors.
The company shows low valuation levels, with an enterprise value at 0.24 times its sales.
Given the positive cash flows generated by its business, the company's valuation level is an asset.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.

The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
The company does not generate enough profits, which is an alarming weak point.

Source: Surperformance

Source: MSCI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Global Valuation (Composite)	Capi.($)
MOLINA HEALTHCARE, INC.		12.52B
UNITEDHEALTH GROUP INC.		279B
CIGNA		83.35B
ELEVANCE HEALTH, INC.		78.96B
HUMANA INC.		28.66B
CENTENE CORPORATION		16.22B
ALIGNMENT HEALTHCARE, INC.	-	2.71B
PROGYNY, INC.		2.08B
CLOVER HEALTH INVESTMENTS, CORP.	-	1.55B
Average		56.13B
Weighted average by Cap.